TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro.
Tremblay
Cécile L
CL
Giguel
Françoise
F
Chou
Ting-Chao
TC
Dong
Huajin
H
Takashima
Katsunori
K
Hirsch
Martin S
MS
D044966:Anti-Retroviral Agents / Q000494:pharmacology*; D065100:CCR5 Receptor Antagonists; D002478:Cells, Cultured; D004357:Drug Synergism; D015497:HIV-1 / Q000187:drug effects*; D007093:Imidazoles / Q000494:pharmacology*; D013454:Sulfoxides
D044966:Anti-Retroviral Agents; D065100:CCR5 Receptor Antagonists; D007093:Imidazoles; D013454:Sulfoxides; C506967:cenicriviroc